For the Inventor, By the Inventor

Enter assignee name

Wakamoto Pharmaceutical Co., Ltd.

USPTO Granted Patents = 39

CIPO Patents = 1

EPO Patents = 6

Trademarks = 5

Forward Citations = 298

Loading Chart...

Loading Chart...

99 inventors (with patents filed for the assignee):

Hidekazu Suzuki (8 out of 35 patents)

Masayoshi Goto (8 out of 13 patents)

Touru Oguma (7 out of 7 patents)

4. Makoto Maeda (6 out of 16 patents)

5. Masanobu Takeuchi (6 out of 6 patents)

6. Shohei Sawaki (6 out of 6 patents)

7. Haruhisa Hirata (5 out of 5 patents)

8. Yoshihiro Horio (5 out of 5 patents)

9. Yasuhiro Ootake (5 out of 5 patents)

10. Satoshi Yamazaki (4 out of 73 patents)

11. Hatsunori Toyofuku (4 out of 4 patents)

12. Mitsuzi Agata (4 out of 4 patents)

13. Sinji Inukai (4 out of 4 patents)

14. Toshio Kuroda (4 out of 4 patents)

15. Hiroki Maruyama (3 out of 22 patents)

39 patents: Sort by Forward Citations

1. 11096889 - Thermo-responsive gelling artificial lacrima (2021-08-24),

2. 10849918 - Composition for optic nerve protection (2020-12-01),

3. 10532026 - Thermo-responsive gelling artificial lacrima (2020-01-14),

4. 9456980 - Latanoprost-containing aqueous pharmaceutical composition (2016-10-04),

5. 9308150 - Liquid agent container (2016-04-12),

6. 8945533 - Oral cavity composition (2015-02-03),

7. 8741876 - Therapeutic agent for ulcerative colitis (2014-06-03),

8. 8153601 - Azithromycin-containing aqueous pharmaceutical composition and a method for the preparation of the same (2012-04-10),

9. 7700106 - Therapeutic agent for ulcerative colitis (2010-04-20),

10. 7612115 - Aqueous pharmaceutical compositions (2009-11-03),

11. 7225949 - Liquid drug container (2007-06-05),

12. 7150986 - Lactic acid bacteria-containing probiotics products (2006-12-19),

13. 7105512 - Ophthalmic aqueous pharmaceutical preparation (2006-09-12),

14. 6849419 - Monoclonal antibody hybridoma immunoassay method and diagnosis kit (2005-02-01),

15. 6777197 - Method and test kit for measuring immunoglobulins reactive with amylase as indication of crohn's disease (2004-08-17),

Wakamoto Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company specializing in the research, development, and manufacture of high-quality healthcare products. With a strong commitment to improving people's well-being, Wakamoto offers a wide range of innovative pharmaceuticals, over-the-counter drugs, and dietary supplements. Our mission is to contribute to society by providing safe and effective solutions for various health conditions. Visit our website to learn more about our company and product portfolio.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

39 Patents

#823 in Tokyo

#1,960 in Japan

#16,954 in the World

Wakamoto Pharmaceutical Co., Ltd.

Forward Citations = 298

99 inventors:

Hidekazu Suzuki (8 out of 35 patents)

Masayoshi Goto (8 out of 13 patents)

Touru Oguma (7 out of 7 patents)

4. Makoto Maeda (6 out of 16 patents)

5. Masanobu Takeuchi (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…